Shares of Johnson Matthey PLC (LON:JMAT – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the five ratings firms that are covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is GBX 2,298.33.
A number of research firms recently issued reports on JMAT. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 2,400 price objective on shares of Johnson Matthey in a report on Monday, July 6th. Berenberg Bank increased their target price on shares of Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the company a “buy” rating in a research report on Monday, June 1st. UBS Group reissued a “neutral” rating and set a GBX 2,200 target price on shares of Johnson Matthey in a research report on Friday, May 22nd. Finally, Jefferies Financial Group restated a “restricted” rating on shares of Johnson Matthey in a research note on Friday, May 29th.
Check Out Our Latest Report on Johnson Matthey
Johnson Matthey Stock Down 1.1%
Johnson Matthey (LON:JMAT – Get Free Report) last released its earnings results on Thursday, May 28th. The company reported GBX 128.50 EPS for the quarter. The company had revenue of GBX 1,257.30 billion for the quarter. Johnson Matthey had a negative return on equity of 4.66% and a negative net margin of 0.76%. Analysts forecast that Johnson Matthey will post 173.4112903 earnings per share for the current year.
Insider Transactions at Johnson Matthey
In other news, insider Alastair Judge purchased 14 shares of the company’s stock in a transaction dated Wednesday, June 10th. The shares were purchased at an average price of GBX 1,990 per share, with a total value of £278.60. Also, insider Richard Pike bought 14 shares of the business’s stock in a transaction on Wednesday, June 10th. The shares were acquired at an average price of GBX 1,990 per share, with a total value of £278.60. In the last three months, insiders have bought 11,482 shares of company stock valued at $24,691,314. Corporate insiders own 0.58% of the company’s stock.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Further Reading
- Five stocks we like better than Johnson Matthey
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
